| Hannah Maye Christensen, ARNP | |
|
1001 Molalla Ave, Oregon City, OR 97045-3788 | |
| (503) 656-5273 | |
| (503) 650-4828 |
| Full Name | Hannah Maye Christensen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1001 Molalla Ave, Oregon City, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346785656 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 201809679NP-PP (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Willamette Falls Medical Center | Oregon city, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Praxis Health Pc | 8325941446 | 167 |
News Archive
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the first quarter ended March 31, 2011.
Malaria affects around 600 million people in the world and leads to an annual death toll of over 2 million. It is the world's most widespread parasitic disease.
Mylan Inc. today confirmed that it was sued by Pfizer in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, 2.5/20 mg, 2.5/40 mg, 5/10 mg, 5/20 mg, 5/40 mg, 5/80 mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg.
› Verified 3 days ago
| Entity Name | Praxis Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821068164 PECOS PAC ID: 8325941446 Enrollment ID: O20040128000241 |
News Archive
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the first quarter ended March 31, 2011.
Malaria affects around 600 million people in the world and leads to an annual death toll of over 2 million. It is the world's most widespread parasitic disease.
Mylan Inc. today confirmed that it was sued by Pfizer in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, 2.5/20 mg, 2.5/40 mg, 5/10 mg, 5/20 mg, 5/40 mg, 5/80 mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hannah Maye Christensen, ARNP Po Box 1517, Pendleton, OR 97801-0410 Ph: (541) 278-4332 | Hannah Maye Christensen, ARNP 1001 Molalla Ave, Oregon City, OR 97045-3788 Ph: (503) 656-5273 |
News Archive
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the first quarter ended March 31, 2011.
Malaria affects around 600 million people in the world and leads to an annual death toll of over 2 million. It is the world's most widespread parasitic disease.
Mylan Inc. today confirmed that it was sued by Pfizer in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, 2.5/20 mg, 2.5/40 mg, 5/10 mg, 5/20 mg, 5/40 mg, 5/80 mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg.
› Verified 3 days ago
Janelle Pinkney Mcleod, PHMNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1425 Beavercreek Rd, Oregon City, OR 97045 Phone: 503-722-6577 Fax: 503-655-8595 | |
Ms. Sherry Lynne Chenell, MS, PMHNP, PMHCNS Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13663 S Spangler Rd, Oregon City, OR 97045 Phone: 503-957-4857 Fax: 503-632-7605 | |
Jessica J Tang, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1500 Division St Ste 80, Oregon City, OR 97045 Phone: 503-215-6085 | |
Mr. Joseph Nathan Jett, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2051 Kaen Rd, Oregon City, OR 97045 Phone: 503-650-5631 | |
Staci S Meador, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1508 Division St Ste 200, Oregon City, OR 97045 Phone: 503-657-1071 Fax: 503-657-3321 | |
Latanya Nikkole Weston, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1425 Beavercreek Rd, Oregon City, OR 97045 Phone: 503-655-8471 | |
Judy Kloos, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1001 Molalla Ave Ste 100, Pacific Medical Group, Oregon City, OR 97045 Phone: 503-656-5273 |